- NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer.
NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer.
The Lancet. Oncology (2013-05-28)
Matthew Dyer, Joanna Richardson, Janet Robertson, Jane Adam
PMID23706983